This promotional site has been created by Britannia Pharmaceuticals Ltd and is intended for healthcare professionals based in countries where APO-go® (apomorphine hydrochloride) has marketing authorisation. UK APO-go® POD Prescribing Information and Adverse Event Reporting can be found here (external non-Britannia website)

29th October, 2025 18:00-19:00 CET